Enzootic Bovine Leukosis: Milk Screening and Verification ELISA: VF-P02210 & VF-P02220

Similar documents
Fluoroquinolones ELISA KIT

Bovine Brucellosis Control of indirect ELISA kits

FELINE CORONAVIRUS (FCoV) [FIP] ANTIBODY TEST KIT

Enzyme immunoassay for the qualitative determination of antibodies against Toxocara canis in human serum or plasma

Title. Author(s)WANG, Chun-Tshen. CitationJapanese Journal of Veterinary Research, 39(2-4): 10. Issue Date DOI. Doc URL.

INFECTIOUS HEPATITIS, PARVOVIRUS & DISTEMPER

ECLIPSE 100. Test para la detección de substancias antibacterianas en leche. Test for detection of inhibitory substances in milk

BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity

The surveillance and control programme for enzootic bovine leukosis (EBL) in Norway

DETECTION OF INHIBITORY SUBSTANCES IN MILK

The use of serology to monitor Trichinella infection in wildlife

Sera from 2,500 animals from three different groups were analysed:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Gliding Motility Assay for P. berghei Sporozoites

OIE Reference Laboratory Reports Activities

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

ECLIPSE 50. Test for the detection of inhibitory substances in milk

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18

OIE Reference Laboratory Reports Activities

Error! Reference source not found. I. SUMMARY OF PRODUCT CHARACTERISTICS

Epidemiological survey and pathological studies on Caprine arthritis-encephalitis (CAE) in Japan

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

EXCEDE Sterile Suspension

Simple Herd Level BVDV Eradication for Dairy

Diurnal variation in microfilaremia in cats experimentally infected with larvae of

The surveillance and control programme for enzootic bovine leukosis (EBL) in Norway

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

Take Control. Prevent BVDV Associated Production Losses

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Data were analysed by SPSS, version 10 and the chi-squared test was used to assess statistical differences. P < 0.05 was considered significant.

Wildlife DNA Sampling Guide. Instructions for the Wildlife DNA Sampling Kit

Visit ABLE on the Web at:

MICRONAUT. diagnostics with passion. Use the reference method and fill the gap of your fully automated system

Feline Heartworm Antibody Test Kit. In vitro diagnostic test for the detection of antibodies to Dirofilaria immitis in feline serum or plasma.

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

Quad Plate User s Manual

Research Article First Report of Bovine Leukemia Virus Infection in Yaks (Bos mutus) in China

(Non-legislative acts) REGULATIONS

DLS Sample Preparation Guide

Surveillance of animal brucellosis

Protocol between the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China and the

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Salmonella Dublin: Clinical Challenges and Control

Vaccine. Diagnostic and Vaccine Chapter. J.H. Wolfram a,, S.K. Kokanov b, O.A. Verkhovsky c. article info abstract

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Introduction. Material and Methods

Detection of Brucellosis in sheep intended for export and local slaughter in Khartoum State, Sudan

Supporting Online Material for

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

Course Curriculum for Master Degree in Poultry Diseases/Veterinary Medicine

PRESCRIBING INFORMATION

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

Prevalence of Bovine Leukemia Virus in Young, Purebred Beef Bulls for Sale in Kansas

EVALUATION OF THE SENSITIVITY AND SPECIFICITY OF THE EHRLICHIA CANIS DIAGNOSTIC TEST: Anigen Rapid E.canis Ab Test Kit

Ren Tip # 84 11/6/15

CERTIFIED REFERENCE MATERIAL IRMM 313

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Article 3 This Directive shall enter into force on the day of its publication in the Official Journal of the European

Supplementary information

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes

Knowledge, attitudes and practices study of dengue viral infection and its association with environmental factors and health issues, Lahore Pakistan

Application of Peristaltic Filling for Flexibility and Accuracy

Topical prevention and treatment of ticks, fleas, mosquitoes, biting flies and lice for monthly use on dogs and puppies 7 weeks of age and older

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and

Name(s): Period: Date:

Ubroseal Dry Cow 2.6 g intramammary suspension for cattle

Veterinary Diagnostics Portfolio Overview. Complete solutions for veterinary testing and pathogen research

A Simply Smart Choice for Point-of-Care Testing

Sensitivity and specificity of an indirect enzyme-linked immunoassay for the diagnosis of Brucella canis infectionindogs

Instruction Manual. 6. Connectors. Latest news and tips can be taken from Be flapscinated.

Stolen Soybeans!!! Introduction. Learning Objectives. Next Generation Science Standards (NGSS) Lesson Introduction

ANTIBIOTICS IN PLASMA

CORAL ESSENTIALS INFORMATION

For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:

SUMMARY OF PRODUCT CHARACTERISTICS FOR CATS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

Classificatie: intern

by adding different antibiotics to sera containing

Import Health Standard. For. Bovine Semen

PCR detection of Leptospira in. stray cat and

The surveillance programme for bovine virus diarrhoea (BVD) in Norway 2016

The surveillance and control programme

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese

CANINE PARVO VIRUS HEALTHY HINTS I S S U E 1 GET THE BEST FOR YOUR BEST FRIENDS!

Official Journal of the European Union

Metacam 1.5 mg/ml oral suspension for dogs

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018)

LOOKING FOR PROFITS IN MILK QUALITY

MATTILSYNET NORWEGIAN FOOD SAFETY AUTHORITY

Protocol for fabrication of microcompartments for long-term culture and imaging of small C. elegans larvae. Henrik Bringmann, March 2011.

MATTILSYNET THE NORWEGIAN FOOD SAFETY AUTHORITY

Break Free from BVD. What is BVD? BVD outbreak in 2013/ cow dairy herd in Staffordshire. Costs Calculation Costs*

SUMMARY OF PRODUCT CHARACTERISTICS

Fact Sheet: Veterinary Natural Health Products and CQM

appropriate healthcare professionals employed at my pharmacy. I understand that I am

VETERINARY PROCEDURES FOR HANDLING RABIES SITUATIONS June 2017

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Transcription:

Enzootic Bovine Leukosis: Milk Screening and Verification ELISA: VF-P02210 & VF-P02220 Introduction Enzootic Bovine Leukosis is a transmissible disease caused by the Enzootic Bovine Leukosis Virus (BLV) which is a retrovirus (lentivirus). It is characterised by a syndrome associating proliferative phenomena (lymphosarcomas, lymphocytosis) and immunodepression. Enzootic Bovine Leukosis is generally not highly contagious and the appearance of clinical symptoms is rare; they often appear several years after primary infection. As no treatment or vaccine is available, prophylaxis for Enzootic Bovine Leukosis depends on early detection accompanied by elimination measures. When to Test Screening for Enzootic Bovine Leukosis is mainly done by testing for specific antibodies. This kit demonstrates the presence of all types of antibodies against the virus (envelope proteins, capsid proteins, etc.). Serological screening is the easiest technique to implement on a large scale. The ELISA test can be used as a screening test to monitor the status of herds or confirm whether or not a herd has been exposed to the Lentivirus. Sampling recommendations Follow Veterinary advice in line with a screening program or suspected outbreak. Assay Description Microtitre plates are supplied pre-coated with the viral antigen (BLV). Diluted samples are incubated in the wells where any antibody specific to BLV binds and forms a complex. Unbound material is washed from the wells. A peroxidase conjugated anti-bovine antibody is added, this conjugate reagent binds to the immune-complex formed on the well surface in the first stage of the test. Unbound conjugate is washed away and TMB substrate is added to the wells. The degree of colour intensity (optical density) is directly related to the amount of antibody to BLV present in the sample. Assay Procedure Add Sample/ Controls Incubate short or long dependant on the milk dilution & Wash Add Enzyme Conjugate Incubate 30 mins or 1 hour dependant on milk dilution used & wash Add Substrate Reagent Incubate 20 mins Add Stop Sol. Read at 450nm For further information or to place an order please contact us at: Guildhay Limited, 6 Riverside Business Centre, Walnut Tree Close, Guildford, Surrey, GU1 4UG England Tel: +44 (0)1483 573727 Fax: +44 (0)1483 574828 Email: sales@guildhay.co.uk Website: http://www.guildhay.co.uk

Enzootic Bovine Leukosis: Milk Screening and Verification ELISA: VF-P02210 & VF-P02220 Interpretation of Results In order to calculate the result for the verification ELISA a correction OD value must first be applied to the sample values, this is the OD value from the coated well minus the OD value from the uncoated well. For interpretation of the results a SP % value must be calculated as follows: FOR THE VERIFICATION ELISA: S/P % = CORRECTED SAMPLE ABSORBANCE x100 CORRECTED POSITIVE CONTROL ABSORBANCE FOR THE SCREENING ELISA: S/P % = (SAMPLE ABSORBANCE NEGATIVE CONTORL ABSORBANCE) x100 (POSITIVE CONTROL ABSORBANCE - NEGATIVE CONTORL ABSORBANCE) RESULT INTERPRETATION FOR SCREENING & VERIFICATION SAMPLES: S/P % Value Lentivirus Antibody status 85 Negative 85-115 Suspect 115 Positive Lentivirus test range: VF-P00302 Maedi-Visna/CAEV: Serum Verification ELISA VF-P02110 Enzootic Bovine Leukosis: Serum Screening ELISA VF-P00303 Maedi-Visna/CAEV: Serum Screening ELISA VF-P02120 Enzootic Bovine Leukosis: Serum Verification ELISA VF-P00310 Maedi-Visna/CAEV: AGID Test P28 VF-P02140 Enzootic Bovine Leukosis: Serum Blocking ELISA gp51 VF-P00320 Maedi-Visna/CAEV: AGID Test Gp135 VF-P02210 Enzootic Bovine Leukosis: Milk Screening ELISA VF-P00410 Enzootic Bovine Leukosis: AGID Test VF-P02220 Enzootic Bovine Leukosis: Milk Verification ELISA For further information or to place an order please contact us at: Guildhay Limited, 6 Riverside Business Centre, Walnut Tree Close, Guildford, Surrey, GU1 4UG England Tel: +44 (0)1483 573727 Fax: +44 (0)1483 574828 Email: sales@guildhay.co.uk Website: http://www.guildhay.co.uk

IMMUNOLOGICAL DIAGNOSIS OF ENZOOTIC BOVINE LEUKOSIS IN MILK BY ELISA METHOD (SENSITIVITY INDEX: 100 MILKS) (960 REACTIONS) VF-P02210-480 480test VF-P02210-960 960test ELISA Bovine Leukosis Milk Screening Version: P02210/11

INTRODUCTION Enzootic Bovine Leukaemia (EBL) is an infectious lymphoproliferative disease in cattle which occurs throughout the world. The disease is caused by an exogenous C-type retrovirus, bovine leukaemia virus (BLV) which established a persistent infection in a sub-population of B lymphocytes by integration of proviral DNA at a number of sites on the cellular DNA. The majority of infected cattle remain healthy for life, although approximately 30% of the infected animals develop a persistent lymphocytosis and a small proportion (up to 10%) develops lymphoid tumours. The disease affects mainly dairy herds and spreads predominantly though horizontal transmission by exposure to blood or secretions containing infected lymphocytes. As no treatment or vaccine is available, the eradication programs are based on identification and elimination of infected animals, which is realised mainly by detection of anti-viral antibodies. The infected cattle produce specific antibodies to the major viral proteins from an early stage of infection. Initially, the agar-gel immunodiffusion (AGID) test for detection of antibodies to the viral surface glycoprotein, gp 51, was widely used. However, the sensitivity of AGID test is limited, and cases have been reported were infected animals fails to produce a detectable antibody response. For this reason, the screening of antibodies is now carried out by ELISA test that is more simple, rapid, and above all more sensitive. This kit is allows detecting antibodies in tank milk. It is based on the use of an ultrapurified virus lysate and can be used to demonstrate the presence of all types of antibodies against the virus (envelope proteins, capsid proteins, etc...). The principle of the test is: PRINCIPLE OF THE TEST 1. All the wells of the polystyrene microplates are coated with viral antigen (BLV). 2. Milk samples to be tested are diluted and incubated in the wells. Any BLV specific antibody present in the milk forms a BLV-antibody immune-complex and remains bound to the wells. 3. After washing, a peroxidase conjugated anti-bovine antibody IgG is added into the wells. This conjugate will bind to the immune-complex. 4. After another washing step, the enzyme substrate (TMB) is added to the conjugate, forming a blue compound becoming yellow after blocking. The intensity of the colour is a function of the rate of antibodies present in the milk sample to be tested. The limit of positivity is set by using a positive control supplied in the kit ("positive control milk") allows detecting the European Standard (E4/250) diluted to 1/100 in bovine milks obtained from uninfected cattle. The positive control must be added into each microplate. PRECAUTIONS FOR USE 1. Do not place the pipette in the mouth when testing reagents. 2. Avoid contact of the substrate (TMB*) with skin, mucous membranes and eyes. 3. Stop-solution» which contains H2SO4*(0,5M) acid, can cause serious burns in case of contact with skin, mucous membranes and eyes. 4. The material in the test kit is non infective, but the milks samples should be regarded as potentially infectious and it is recommended that after the test procedure is completed that all the disposable elements used are put in immersion for a minimum of 1 hour in freshly prepared 5% sodium hypochlorite, or autoclaved at 120 C for a minimum of 1 hour before discarding. * The product s toxicity form is available at the Institut Pourquier. Bovine Leukosis Milk Screening - Version P02210/11 - Page 1/5

KIT CONTENTS and STORAGE OF REAGENTS It is recommended to bring at room temperature (21 C ± 5 C) all the reagents of the kit (except the conjugate) at least one hour before use COMPONENTS QUANTITY STORAGE AND NOTES Monowell Coated microplates Concentrated wash solution (20x) Dilution Buffer 1 sky blue Positive control (freeze-dried) Negative control (freeze-dried) Monoclonal anti - bovine - IgG / peroxydase conjugate Revelation solution 2 (TMB) Ready to use Stop Solution (H2 SO4 0,5M solution) Using Instructions 10 +5 C (± 3 C) If a microplate is not entirely used, it may be stored for later use if it is immediately closed in an airtight container and stored at +5 C (± 3 C). The packaging of the plates leads to the appearance of deposits or crystals at the bottom of the wells, without modifying the reaction. 2 x 100 ml bottles 3 x 120 ml bottles 2 x 2 ml bottles 2 x 2 ml bottles 1 x 1,5 ml bottle 1 x 120 ml bottle 1 x 120 ml bottle +5 C (± 3 C) May form crystals at +5 C (± 3 C), which rapidly disappear at +21 C (± 5 C). A gentle shaking of the solution will accelerate the dissolution of the crystals This solution can also be stored at +21 C (± 5 C) for 1 month, if the vials are closed in a watertight way, in order to be immediately available when needed. The "Concentrated wash solution (20x)" is the same for all the kits of the INSTITUT POURQUIER and can be used equally in the different kits. After dilution, the wash solution can be stored for 3 days at +5 C (± 3 C) +5 C (± 3 C) After reconstitution, the positive and the negative control milks must be stored in aliquots at a temperature -16 C They can be frozen and unfrozen up to three times without loss of activity. A storage at+5 C (± 3 C) will lead to a significant increase of the background noises. +5 C (±3 C) The diluted conjugate solution cannot be stored +5 C (±3 C) This solution can be slightly bluish at +5 C (±3 C) and becomes colourless at +21 C (±5 C). Thus it can be left on the draining board at +21 C (±5 C) up to 1 week (if the vial is well closed in a watertight way), in order to be immediately available when needed. +5 C (±3 C) It can be stored at +21 C (± 5 C) up to 1 month (if the vial is well closed in a watertight way), in order to be immediately available when needed. The same for all the kits of the INSTITUT POURQUIER, it can be used equally in the different kits. Bovine Leukosis Milk Screening - Version P02210/11 - Page 2/5

MATERIALS REQUIRED BUT NOT INCLUDED IN THE KIT 1. Microplates reader 2. Centrifuge 3. Centrifuge tubes and microtubes 4. Vortex or similar 5. Microplate washing system that distributes 300 µl per well 6. Precision micropipettes and multi-dispensing micropipettes (The required precision must be 5% for all the volumes indicated) 7. Disposable pipette tips 8. Distilled water: the water used for the reconstitution of control milks and of the wash solution can be produced by a conventional distillation system or any other high-performance water purification system (reverse osmosis, resin or activated charcoal purification...). 9. Microplate covers (lid, aluminium foil or adhesive) 10. Incubator at +37 C (±3 C) INSTRUCTIONS FOR USE 1) DEPOSITING THE MILK SAMPLES a) Reconstitution of the control milks: - Reconstitute the negative and the positive control with 2 ml distilled water. b) Dispense 100 µl of "Dilution Buffer 1" per well. c) Following figure 1 (see notes 1 and 2), dispense: - 100 µl of undiluted negative control in A1-100 µl of undiluted positive control in B1 and C1-100 µl of each undiluted milk sample to be tested per well. Note: Milk samples may be skimmed or full fat milk. d) Cover the plate (with a lid, aluminium foil or adhesive) e) The user can incubate the milk in two ways: SHORT INCUBATION: LONG INCUBATION AT A LOW TEMPERATURE: 90 minutes (± 5 min.) at 37 C (± 3 C) overnight at +5 C (± 3 C) A N 6 N = Negative control B P.. P = Positive control C P 1 = Sample n 1 D 1 2 = Sample n 2 E 2 3 =... F 3 G 4 Figure 1: Distribution of the milks H 5.. 1 2 3 4 5 6 7 8 9 10 11 12 Bovine Leukosis Milk Screening - Version P02210/11 - Page 3/5

Notes: 1. The individual filling of the 96 wells is sometimes a long process. In order to standardize the milk incubation time, we prepare the controls and milk samples in 96 U-shaped-bottom-well plates. It is therefore possible to transfer them rapidly (column by column) by using a multi-channel pipette. 2. The position of the controls in A1, B1 and C1 is not very important. They may be dispensed anywhere on the plate. It may be better to add several times controls to the same plate in order to establish an average cut-off value. It is recommended to put a repetition of the controls in the centre of the plate. However, it is essential to dilute the samples in the same way as for the controls. 3. In order to check the reaction, the user may also use the European Standard Milk (E4/250) diluted at 1/100 in negative control milk. 4. In the case of the long incubation, if the incubation temperature is not respected, the quality of the discrimination between negative and positive milks will not be modified, but the final level of OD value will be affected. 5. Laboratories, which use automatic methods, may not have enough reagents (i.e. "Concentrated wash solution (20x)" or "Dilution Buffer"). Extra reagents can be supplied free of charge, on request. 2) WASHING a) Dilute a vial of "concentrated (X 20) wash solution" in 1900 ml of distilled water. This solution is hereafter called "wash solution". The dilution can be carried out before the elimination of crystals appeared at +5 C (±3 C), so long as the whole 100 ml vial is used. b) Empty the content of the plate by «flick-off» or better by a manual or automatic method. c) Fill all the wells of the plate with the wash solution; then empty them again. d) Repeat the step c) twice (a total of 3 washes). Notes: 1. If milks are skimmed (or taken under the cream), this type of washing is sufficient. With full fat milk, it can be necessary to modify this method of washing: if a visual control reveals whitish traces in the wells, it is advised to leave the solution of washing in contact 1 to 3 times 3 minutes. Indeed, these contact times allow eliminating the fat particles that are likely to fix the conjugate in the next step in a non-specific way. 2. When several plates are processed at the same time, it is possible, it is possible (in order to synchronize all the steps) to leave the plates full of «wash solution» during one hour without any modification on the validity of the test. 3) DEPOSITING THE CONJUGATE The dilution and the incubation time of the conjugate depend on the way of incubation used for the milk samples: If the user has chosen a SHORT INCUBATION PERIOD FOR THE SAMPLES: - Dilute the conjugate to 1/100 in "Dilution buffer 1" and dispense 100 µl per well. - Cover the plate (with a lid or aluminium foil) and incubate for 30 minutes (± 3 min) at 37 C (± 3 C) If the user has chosen a LONG INCUBATION PERIOD FOR THE SAMPLES AT LOW TEMPERATURE: - Dilute the conjugate to 1/400 in "Dilution buffer 1" and dispense 100 µl per well. - Cover the plate (with a lid or aluminium foil) and incubate for 1 hour (± 5 min) at 37 C (± 3 C) 4) WASHING a) Empty the content of the plate by «flick-off» or by some other way or by an automatic method. b) Fill all the wells on the plate with the wash solution; then empty them again. c) Repeat the step b) twice (total of 3 washes) Note: 1. Particular care with the last wash is very important in getting a good test result. 2. If the wash is carried out with a manual method, it is possible after the last wash to drum the microplate on a dry towel in order to empty the wells completely. 5) REVELATION Bovine Leukosis Milk Screening - Version P02210/11 - Page 4/5

a) Dispense 100 µl of "Revelation Solution 2" ready to use per well. b) Incubate the plates at +21 (± 5 C) for 20 minutes (away from the light). c) Dispense 100 µl of "Stop Solution" per well. d) Shake gently the plate until the coloured solution is homogenized. Wipe carefully the underside of the plate. Note: 1) The 20-minute revelation period, which is indicated in the method, gives the O.D. values provided in the paragraph "INTERPRETATION", when implemented in our laboratories. However the rate of colour revelation can be slightly affected by different factors (quality of the washes, quality of the water used, precision of the pipetting, temperature of the reaction...). Regarding the work conditions, the revelation step may give OD values higher or lower than those expected. So, the user may stop the reaction after 20 minutes (±10 minutes). 2) The reading can be done up to 1 hour after having stopped the reaction on condition that the plates are kept in the dark. 6) READING Read the optical densities at 450 nm (OD.450). The photometer must first be blanked on air. The results can be considered reliable if: VALIDATION CRITERIA - the mean positive control OD.450 value is > 0.300 and - the ratio between the mean OD.450 of the positive control and the OD.450 of the negative control is equal or greater than 2. INTERPRETATION Calculate for each sample the percentage S/P: S/P% = 100 x (OD.450 of the sample OD.450 of the negative control) ) (mean OD.450 of the positive control OD.450 of the negative control) Any milk sample (individual or pools) with a S/P% equal or lower than 60% is considered coming from a herd which has not been in contact with the BLV virus. Any milk sample (individual or pools) with a S/P% between 60% and 70% is considered as doubtful. Any milk sample (individual or pools) with a S/P% equal or higher than 70% is considered coming from a herd, which has been in contact with the BLV virus. Note: It is possible to confirm milks found positive by an ELISA method using a control well. (Please contact the Institut Pourquier in order to obtain the microplates corresponding for this control). : : Modification in the using instructions LEGEND Bovine Leukosis Milk Screening - Version P02210/11 - Page 5/5